|
|
With more than 50 products currently available and more than 30 pipeline products, Par Pharmaceutical Companies’ two divisions – Par Pharmaceutical and Strativa Pharmaceuticals – are committed to bringing people the pharmaceutical products they need for a full range of life stages and lifestyles.
Strategic partnerships are an integral component of the Company's growth strategy. We seek to introduce new products through research and development programs, distribution and other agreements, including licensing of authorized generics and proprietary products with partners located throughout the world.
|
|
|